TransThera Sciences (HKG:2617) completed the sale of nearly HK$195 million worth of shares, according to a Hong Kong bourse filing Tuesday.
The firm sold 2.1 million shares priced at HK$92.85 apiece to raise funds for the clinical development of its drug candidates.
The shares represent 0.69% of the company's issued H shares and 0.53% of its total issued shares following the sale.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.